These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic stem cell transplantation: Middle East/North Africa regional consensus on prevention, diagnosis and management. Al Jefri AH; Abujazar H; Al-Ahmari A; Al Rawas A; Al Zahrani Z; Alhejazi A; Bekadja MA; Ibrahim A; Lahoucine M; Ousia S; Bazarbachi A Bone Marrow Transplant; 2017 Apr; 52(4):588-591. PubMed ID: 27892944 [TBL] [Abstract][Full Text] [Related]
4. Nursing role in the assessment and care of hepatic sinusoidal obstruction syndrome patients: a consensus paper by the "Gruppo Italiano Trapianto di Midollo Osseo". Botti S; Agreiter I; Orlando L; Gargiulo G; Bonifazi F; Banfi MM; Cappucciati L; Caffarri C; De Cecco V; Deiana GM; Gavezzotti M; Magarò A; Netti MG; Pignatelli AC; Rostagno E; Samarani E; Cardoso JS; Soave S; Valente CM; Vedovetto A; Zecca M; Luminari S; Merli F; Guberti M Support Care Cancer; 2020 Nov; 28(11):5125-5137. PubMed ID: 32056012 [TBL] [Abstract][Full Text] [Related]
6. Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children. Qureshi A; Marshall L; Lancaster D Pediatr Blood Cancer; 2008 Apr; 50(4):831-2. PubMed ID: 18286502 [TBL] [Abstract][Full Text] [Related]
7. Defibrotide for children and adults with hepatic veno-occlusive disease post hematopoietic cell transplantation. Corbacioglu S; Richardson PG Expert Rev Gastroenterol Hepatol; 2017 Oct; 11(10):885-898. PubMed ID: 28825848 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement. Mahadeo KM; Bajwa R; Abdel-Azim H; Lehmann LE; Duncan C; Zantek N; Vittorio J; Angelo J; McArthur J; Schadler K; Chan S; Tewari P; Khazal S; Auletta JJ; Choi SW; Shoberu B; Kalwak K; Harden A; Kebriaei P; Abe JI; Li S; Moffet JR; Abraham S; Tambaro FP; Kleinschmidt K; Richardson PG; Corbacioglu S; Lancet Haematol; 2020 Jan; 7(1):e61-e72. PubMed ID: 31818728 [TBL] [Abstract][Full Text] [Related]
10. In brief: Defibrotide (Defitelio) for hepatic veno-occlusive disease. Med Lett Drugs Ther; 2016 Sep; 58(1503):120. PubMed ID: 27603963 [No Abstract] [Full Text] [Related]
11. Optimal approach to prevent veno-occlusive disease following hematopoietic stem cell transplantation in children. Hassan Z Pediatr Transplant; 2010 Sep; 14(6):683-7. PubMed ID: 20353406 [No Abstract] [Full Text] [Related]
12. Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation. Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ Br J Haematol; 2017 Jul; 178(1):112-118. PubMed ID: 28444784 [TBL] [Abstract][Full Text] [Related]
13. The budget impact and cost-effectiveness of defibrotide for treatment of veno-occlusive disease with multi-organ dysfunction in patients post-hematopoietic stem cell transplant. Veenstra DL; Guzauskas GF; Villa KF; Boudreau DM J Med Econ; 2017 May; 20(5):453-463. PubMed ID: 28008770 [TBL] [Abstract][Full Text] [Related]
14. Primary prophylaxis of invasive fungal diseases in allogeneic stem cell transplantation: revised recommendations from a consensus process by Gruppo Italiano Trapianto Midollo Osseo (GITMO). Girmenia C; Barosi G; Piciocchi A; Arcese W; Aversa F; Bacigalupo A; Bandini G; Bosi A; Busca A; Castagnola E; Caselli D; Cesaro S; Ciceri F; Locasciulli A; Locatelli F; Mikulska M; Pagano L; Prete A; Raiola AM; Rambaldi A Biol Blood Marrow Transplant; 2014 Aug; 20(8):1080-8. PubMed ID: 24582783 [TBL] [Abstract][Full Text] [Related]
15. High Variability in the Reported Management of Hepatic Veno-Occlusive Disease in Children after Hematopoietic Stem Cell Transplantation. Skeens MA; McArthur J; Cheifetz IM; Duncan C; Randolph AG; Stanek J; Lehman L; Bajwa R; Biol Blood Marrow Transplant; 2016 Oct; 22(10):1823-1828. PubMed ID: 27496218 [TBL] [Abstract][Full Text] [Related]
16. Safety and effects of prophylactic defibrotide for sinusoidal obstruction syndrome in hematopoietic stem cell transplantation. Park M; Park HJ; Eom HS; Kwon YJ; Park JA; Lim YJ; Yoon JH; Kong SY; Ghim TT; Lee HW; Yun T; Park BK Ann Transplant; 2013 Jan; 18():36-42. PubMed ID: 23792499 [TBL] [Abstract][Full Text] [Related]
18. Allogeneic hematopoietic cell transplantation in systemic mastocytosis: is there a high risk for veno-occlusive disease? Ustun C; Smith A; Cayci Z; Courville EL; Corbacioglu S; Akin C; Horny HP; Valent P; Devine S; Weisdorf DJ Eur J Haematol; 2016 Jun; 96(6):655-7. PubMed ID: 26679533 [No Abstract] [Full Text] [Related]
19. Complete resolution of transplantation-associated thrombotic microangiopathy and hepatic veno-occlusive disease by defibrotide and plasma exchange. Beşişik SK; Oztürk GB; Calişkan Y; Sargin D Turk J Gastroenterol; 2005 Mar; 16(1):34-7. PubMed ID: 16252186 [TBL] [Abstract][Full Text] [Related]
20. Best practice for peripheral blood progenitor cell mobilization and collection in adults and children: results of a Società Italiana Di Emaferesi e Manipolazione Cellulare (SIDEM) and Gruppo Italiano Trapianto Midollo Osseo (GITMO) consensus process. Pierelli L; Perseghin P; Marchetti M; Accorsi P; Fanin R; Messina C; Olivieri A; Risso M; Salvaneschi L; Bosi A; ; Transfusion; 2012 Apr; 52(4):893-905. PubMed ID: 21980921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]